VST BIO Corporation
PrivateLast Round
Series A
Mar 17, 2026
Total Funding Raised
$45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VST BIO Corporation is a biotechnology company developing first-in-class antibody therapies for vascular-related diseases such as ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VST BIO Corporation Comparables
Compare VST BIO Corporation with similar companies based on industry and business-model similarity.
No public comparables are available for VST BIO Corporation. Request access to learn about comparables coverage.
Request accessVST BIO Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 17, 2026 |
VST BIO Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coefficient Giving | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
$45M round led by Coefficient Giving
VST BIO Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VST BIO Corporation's valuation, stock price, and market status.
Is VST BIO Corporation a public or private company?
VST BIO Corporation is a private company.
What is the current stock price of VST BIO Corporation?
VST BIO Corporation is a private company with no public stock price. No recent secondary market data is available.
How much is VST BIO Corporation worth (valuation)?
Valuation information for VST BIO Corporation is not publicly available.
Can I buy VST BIO Corporation stock?
VST BIO Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VST BIO Corporation's last funding round?
VST BIO Corporation's most recent funding round was Series A on March 17, 2026.
Who are the main investors in VST BIO Corporation?
Key investors in VST BIO Corporation include Coefficient Giving.
Will VST BIO Corporation IPO soon?
No public IPO plans have been announced for VST BIO Corporation.
How can I track VST BIO Corporation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VST BIO Corporation's secondary market activity and sign up for updates.